Outcomes of 54 cases of monkeypox (MPX) in London: fewer early symptoms but higher rates of genital lesions – urgency of funding sexual health
2 July 2022. Related: Early access, Coinfections and complications.
2022
Featured HTB July 2022 (1 July 2022) now online
1 July 2022. Related: Editorial.
Introduction to ART: i-Base guide (June 2022)
1 July 2022. Related: Editorial.
Sending unused meds to Ukraine: emergency appeal
1 July 2022. Related: Editorial.
Organisations to support Ukraine
1 July 2022. Related: Editorial.
Monkeypox crisis in the UK needs urgent funding: sex, vaccines and Pride
1 July 2022. Related: Special reports, Coinfections and complications.
29th Conference on Retroviruses and Opportunistic Infections (CROI 2022): final report
1 July 2022. Related: Conference reports.
CROI 2022: NAMSAL study comparing DTG to EFV400 in Cameroon: week 192 results
1 July 2022. Related: Conference reports, Treatment strategies.
Lenacapavir gets positive opinion for approval in the EU to treat MDR HIV
1 July 2022. Related: Antiretrovirals.
Combination bNAb’s sustain viral suppression for 40 weeks: phase 1 results
1 July 2022. Related: Antiretrovirals, Cure research.
Dual bNAbs in children: dose-finding and safety data on VRC01LS and 10-1074 in the Tatelo study
1 July 2022. Related: Paediatric care.
UK offers limited vaccine to gay and bisexual men at risk of monkeypox: full dose offered in NYC
1 July 2022. Related: Coinfections and complications.
Full results from ANCHOR study published in NEJM
1 July 2022. Related: Cancer and HIV.
INSTIs and cardiovascular events in the RESPOND cohort: early increase at six months normalises after two years
1 July 2022. Related: Side effects, Lipodystrophy and metabolic complications.
Gonorrhoea vaccine might halve infections and help combat drug resistance
1 July 2022. Related: Coinfections and complications.
COVID update: new waves of BA.4 and BA.5 in the UK – all omicron variants linked to reduced antibody responses to vaccines
1 July 2022. Related: Coinfections and complications, COVID-19: vaccine research, COVID-19.
Importance of booster vaccine to protect against emergent COVID-19 variants
1 July 2022. Related: Coinfections and complications, COVID-19: vaccine research, COVID-19.
Similar COVID-19 vaccination responses in HIV positive people on ART and with good CD4 counts compared to HIV negative controls
1 July 2022. Related: Coinfections and complications, COVID-19: HIV and COVID-19 coinfection, COVID-19: vaccine research, COVID-19.
US study reports higher rates of breakthrough COVID in HIV positive vs negative controls
1 July 2022. Related: Coinfections and complications, COVID-19: HIV and COVID-19 coinfection, COVID-19: vaccine research, COVID-19.
BMJ reports UK government failed to protect doctors during COVID-19
1 July 2022. Related: Coinfections and complications, COVID-19.
Fantastic voyage: tracking adherence sensors in PrEP meds
1 July 2022. Related: HIV prevention and transmission.
UK increases funding to UNAIDS: still dramatically lower than before last years’ 80% cut
1 July 2022. Related: Other news.
Future meetings and webinars 2022
1 July 2022. Related: Future meetings.
HTB: no. 7 (1 July 2022) PDF downloads
1 July 2022. Related: PDFs.
HTB June 2022 (1 June 2022)
1 June 2022. Related: Editorial.
29th Conference on Retroviruses and Opportunistic Infections (CROI 2022): further reports
1 June 2022. Related: Conference reports.
CROI 2022: Updates from the VESTED study
1 June 2022. Related: Conference reports, Treatment strategies.
CROI 2022: Switching to dolutegravir for adults on stable PI-based second-line ART
1 June 2022. Related: Conference reports, Treatment strategies.
Lenacapavir in MDR HIV: phase 3 results of CAPELLA study published
1 June 2022. Related: Antiretrovirals.
ViiV licenses long-acting cabotegravir (CAB-LA) for generic access
1 June 2022. Related: Antiretrovirals, Treatment access, HIV prevention and transmission.
Monkeypox outbreak: Update and further information
1 June 2022. Related: Special reports, Coinfections and complications.
Draft BHIVA guidelines online for comment: deadline 9 June
1 June 2022. Related: Guidelines.
Monkeypox cases in gay men in the UK: BHIVA and ECDC rapid statements
1 June 2022. Related: Coinfections and complications.
Monkeypox DNA in semen supports advice to use condoms for eight weeks after infection has cleared
1 June 2022. Related: Coinfections and complications.
Risk of monkeypox becoming endemic in Europe: ECDC assessment
1 June 2022. Related: Coinfections and complications.
Seven cases of monkeypox virus in the UK from 2018 to 2021
1 June 2022. Related: Coinfections and complications.
Monkeypox: Q&A factsheet
1 June 2022. Related: Coinfections and complications.
Implications of SARS-CoV-2 in gut tissue for transmission of COVID-19 and long COVID
1 June 2022. Related: COVID-19.
HTB: no. 6 (1 June 2022) PDF downloads
1 June 2022. Related: PDFs.
Family of Greek activist Zak Kostopoulos decry minimal sentence given to his killers
5 May 2022. Related: Other news.
Featured HTB May 2022 (2 May 2022)
2 May 2022. Related: Editorial.
29th Conference on Retroviruses and Opportunistic Infections (CROI 2022): third reports
2 May 2022. Related: Conference reports.
CROI 2022: Dolutegravir plus recycled tenofovir rather than switch to AZT: public health approach to second-line ART
2 May 2022. Related: Conference reports, Antiretrovirals, Treatment strategies.
CROI 2022: Other COVID-19 studies
2 May 2022. Related: Conference reports, Coinfections and complications, COVID-19.
FDA approves dispersible dolutegravir/abacavir/3TC for children
2 May 2022. Related: Antiretrovirals.
Access to ibalizumab uncertain in Europe: TaiMed looking for new partner after Thera quits
2 May 2022. Related: Antiretrovirals, Treatment access.
Asymptomatic COVID-19 is common in people living with HIV
2 May 2022. Related: Coinfections and complications, COVID-19: HIV and COVID-19 coinfection, COVID-19.
Longest COVID-19 infection lasted 505 days in an immunocompromised person in London
2 May 2022. Related: Coinfections and complications, COVID-19: HIV and COVID-19 coinfection, COVID-19: pathogenesis, COVID-19.
Herd immunity unlikely to control COVID-19: opinion article from US NIAID
2 May 2022. Related: Coinfections and complications, COVID-19: transmission & prevention, COVID-19.
The challenges of prioritising access to molnupiravir and nirmatrelvir–ritonavir for COVID-19
2 May 2022. Related: Coinfections and complications, COVID-19: complications, COVID-19.
Increased risk of blood clots after COVID-19: higher with underlying conditions and more severe symptoms
2 May 2022. Related: Coinfections and complications, COVID-19: complications, COVID-19.
Two new platform vaccines against COVID-19 report phase 3 results
2 May 2022. Related: Coinfections and complications, Other news, COVID-19: vaccine research, COVID-19.
A&E adopts opt-out HIV testing in London, Manchester, Salford and Brighton
2 May 2022. Related: HIV prevention and transmission.
Zimbabwe decriminalises HIV transmission
2 May 2022. Related: HIV prevention and transmission, Other news.
Community webinar series on HIV cure-related cell and gene therapy
2 May 2022. Related: Cure research.
HTB: no. 5 (2 May 2022) PDF downloads
2 May 2022. Related: PDFs.
HTB April 2022 (1 April 2022)
1 April 2022. Related: Editorial.
29th Conference on Retroviruses and Opportunistic Infections (CROI 2022): second reports
1 April 2022. Related: Conference reports.
CROI 2022: Webcasts now online and open access
1 April 2022. Related: Conference reports.
CROI 2022: Islatravir studies for HIV treatment and PrEP
1 April 2022. Related: Conference reports, Antiretrovirals.
CROI 2022: UK study reports diabetes mellitus in 9% of HIV positive Africans in the UK on stable ART
1 April 2022. Related: Conference reports, Coinfections and complications.
CROI 2022: Life expectancy reduced by eight years following hospitalisation for a mental health condition in South Africa
1 April 2022. Related: Conference reports, Coinfections and complications.
CROI 2022: Long COVID persists for over a year: evidence for divergent immune responses
1 April 2022. Related: Conference reports, Coinfections and complications, COVID-19: long COVID, COVID-19.
CROI 2022: Risk factors for NAFLD and proteinuria in HIV positive people on ART
1 April 2022. Related: Conference reports, Coinfections and complications.
CROI 2022: UK study shows PEP is started earlier using home starter packs
1 April 2022. Related: Conference reports, HIV prevention and transmission.